➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Colorcon

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Litigation Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Keryx Biopharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-12-19 1 United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent…25 PageID #: 2 patent”); 9,328,133 (the “’133 patent”); 9,387,191 (the “’191 patent”); and 9,757,416… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C External link to document
2019-04-10 17 Complaint - Amended United States Patent Nos. 7,767,851 (the “’851 patent”); 8,093,423 (the “’423 patent”); 8,299,298 (the…(the “’298 patent”); 8,338,642 (the “’642 patent”); 8,609,896 (the “’896 patent”); 8,754,257 (the “’257…’257 patent”); 8,754,258 (the “’258 patent”); 8,846,976 (the “’976 patent”); 8,901,349 (the “’349 patent9,050,316 (the “’316 patent”); 9,328,133 (the “’133 patent”); and 9,757,416 (the “’416 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Merck
Johnson and Johnson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.